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http:WHAT THIS PAPER ADDS
The role of inﬂammation in the early pathophysiological process of aortic abdominal aneurysm (AAA) is yet to be
deﬁned. Molecular imaging studies with [18F]-ﬂourodeoxyglucose-positron emission tomography (FDG-PET)
have failed to show a clear uptake in asymptomatic AAAs. Consequently, alternative PET tracers, signalling for
other aspects of the inﬂammatory process, need to be evaluated in order to further investigate the patho-
physiology of aneurysm formation.
In this study two potential PET-tracer candidates for this purpose; [11C]-PK11195 and [11C]-D-deprenyl, previously
associated with high uptake in molecular imaging of inﬂammatory conditions, were evaluated in AAA for the ﬁrst
time.Objectives: The aim of this study was to investigate the relevance of inﬂammation in the pathogenesis of
abdominal aortic aneurysm (AAA) in vivo with two novel positron emission tomography (PET) tracers: [11C]-
PK11195 which targets the translocator protein (18 kDa) expressed on macrophages and [11C]-D-deprenyl with
a yet unknown target receptor expressed in chronic inﬂammation.
Design: Prospective clinical study.
Materials/methods: Five patients were examined with [11C]-PK11195-positron emission tomography/computed
tomography (PET/CT) and 10 with [11C]-D-deprenyl-PET/CT. Nine large AAAs (54e66 mm) scheduled for repair and
six small AAA (35e44 mm). All 15 patients were male and the AAAs were all asymptomatic. Regional activity was
measured as standardised uptake values (SUVs) and retention index was calculated. Biopsies were taken from the
aneurysm wall for histological examinations, in the nine patients operated on.
Results: No aortic uptake was recorded on the visual inspection, neither with [11C]-PK11195 nor with [11C]-D-
deprenyl. For [11C]-PK11195 the median SUV of the AAA wall was 0.9 (range 0.8e1.0) and for [11C]-D-deprenyl,
0.7 (range 0.4e1.2). No increased uptake was seen in the aneurysmal infrarenal aorta compared with the non-
aneurysmal suprarenal aorta. Histological examination of the aneurysm wall showed high inﬂammatory cell
inﬁltration with lymphocytes and macrophages.
Conclusions: The chronic inﬂammation observed in the vessel wall was not detectable with [11C]-PK11195 and
[11C]-D-deprenyl. In order to study the relevance of the inﬂammation in the pathogenesis of AAA in vivo other PET
tracers need to be investigated.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 13 August 2012, Accepted 8 January 2013, Available online 8 February 2013
Keywords: Abdominal aortic aneurysm, [11C]-PK11195, [11C]-D-deprenyl, Positron emission tomography,
Histology, InﬂammationThe aetiology of degenerative abdominal aortic aneu-
rysms (AAAs) is mostly unknown. One of the observed
features of the arterial wall in aneurysmal disease is the
degradation of the connective tissue in the media layer. An
increased proteolytic activity of matrix metalloproteinase,rresponding author. Tel.: þ46 (0) 18 611 00 00; fax: þ46 (0) 18 611
il address: gustaf@tegler.se (G. Tegler).
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//dx.doi.org/10.1016/j.ejvs.2013.01.011responsible for the degeneration of elastic lamellae and
extracellular matrix proteins, has been demonstrated.1,2
Another observed characteristic is a chronic inﬂamm-
ation with large amounts of inﬂammatory cells, T- and
B-lymphocytes as well as macrophages,3 with a possible
role in the pathogenesis of AAA.
Recent studies have shown that this inﬂammatory
activity is not sufﬁciently metabolic active to be detected
by [18F]-ﬂourodeoxyglucose-positron emission tomography
(FDG-PET) in asymptomatic AAAs.4e6 Consequently, alter-
native PET tracers, signalling for other aspects of the
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further investigate the pathophysiology of aneurysm
formation. Two potential PET-tracer candidates for this
purpose were identiﬁed:
1) [11C]-PK11195 is a radio ligand that was developed in
the early 1980s and targets the translocator protein
(18 kDa) (TSPO) formerly known by the terms ‘u3
receptor’ and ‘peripheral benzodiazepine receptors’.7,8
The translocator protein (18 kDa) (TSPO) is expressed on
macrophages9 and [11C]-PK11195 has shown promising
results in visualising the inﬂammation in large-vessel
vasculitis10 and in active knee rheumatoid synovitis.11
2) [11C]-D-deprenyl is a radio ligand with yet unknown
exact binding site or mechanisms. Being the isomer to
selegillin, a selective and irreversible blocker to the
monoamine oxidase-B (MAO-B) enzyme, does, however,
indicate that D-deprenyl is a receptor-targeting tracer.
The tracer has a small molecular size and a neutral
electric charge, which makes it pass all membranes,
including the bloodebrain barrier. The tracer has shown
a high activity in synovium in active rheumatoid arthritis
as well as in patients with chronic neck pain due to
whiplash-associated disorders,12,13 suggesting that
[11C]-D-deprenyl may be useful in visualising chronic
inﬂammation.
The aim of the present report was to evaluate these two
new PET tracers, [11C]-PK11195 and [11C]-D-deprenyl, on
patients with small and large asymptomatic AAAs for the ﬁrst
time and compare this with the non-aneurysmal suprarenal
aorta and with histology on wall biopsies from large
asymptomatic AAAs. We hypothesised that a histologically
detectable chronic inﬂammation in large asymptomatic AAAs
would also be detectable in vivo in the wall of small and/or
large asymptomatic AAAs with [11C]-PK11195 and/or with
[11C]-D-deprenyl radio ligands with positron emission
tomography/computed tomography (PET/CT) scans.PATIENTS AND METHOD
The Regional Ethics Committee of Uppsala/Örebro
approved the study and all patients gave written informed
consent. Inclusion criteria were presence of an infra-renal
asymptomatic AAA, male gender, cardio-pulmonary ﬁt forTable 1. Baseline characteristic of the studied patients.
[11C]-PK11195
Small AAA
n ¼ 1
L
n
Age (years)a 65 6
Aneurysms size (mm)a 35 6
Smoking habits (n),
non/former/current
0/1/0 0
Hypertension (treatment) 1 4
ASA/Statin/ASA & Statin 0/0/1 1
Time from PET to
surgery (days)a
e 4
a Median (range).open surgery and lack of present or a history of immuno-
modulatory medication. A total of 15 men were included.
Five subjects were scanned with [11C]-PK11195 PET/CT, four
with large asymptomatic AAAs (range 58e66 mm) sched-
uled for surgical repair and one with a small (35 mm) AAA
under surveillance. Ten subjects were investigated with
[11C]-D-deprenyl PET/CT, including ﬁve large AAAs (range
54e64 mm) and ﬁve small (range 35e44 mm). Baseline
clinical characteristics are displayed in Table 1. All the large
AAAs (n ¼ 9) had an open repair procedure during which
biopsies were obtained from the anterior wall of the
aneurysms. According to the study protocol, biopsies, con-
sisting of the full thickness of the vessel wall, were to be
taken from locations with tracer uptake or, if no uptake
were to be seen, from the anterior wall. There was no 30-
day postoperative mortality.
PET/CT protocol
The scanner used was a GE Discovery ST16 (General Elec-
trics, Waukesha, WI, USA). A low-dose CT scan without
contrast was performed prior to the PET scan for anatomical
correlation and attenuation correction. All the patients
investigated with [11C]-PK11195 did a static scan covering
the abdomen starting 35 min after injection with 300 s per
bed position (15-cm stepwise bed movement) and three of
the patients also did dynamic scans covering the AAA area
from 0 to 25 min after tracer injection. All the patients
examined with [11C]-D-deprenyl did both static and dynamic
scans.
Volumes of interest (VOI) were constructed using the
software VOIager 4.0.7, a PET image analysis research tool
developed for internal use at PET-Centre, Uppsala, Sweden.
VOIs were deﬁned on axial projections of the CT, where
VOIs of the vessel only contained the vessel wall. The mean
values of three VOIs of the aneurysm wall were compared
to multiple VOIs of suprarenal aorta, blood and liver,
respectively (Fig. 1).
The regional activity was measured as mean standardised
uptake value (SUV). In order to eliminate interindividual
variations in the blood radioactivity content as a cause of
SUV variation, a retention index was calculated by dividing
the SUV value obtained from the static series in the AAA
and suprarenal aorta with the SUV integral obtained from
the dynamic series in blood.[11C]-D-deprenyl
arge AAA
¼ 4
Small AAA
n ¼ 5
Large AAA
n ¼ 5
6 (65e75) 65 (60e65) 66 (65e71)
1 (58e66) 41 (35e44) 56 (54e64)
/2/2 1/1/3 3/1/1
5 3
/1/0 1/1/2 0/1/2
6 (21e56) e 5 (1e56)
Figure 1. Example of VOI placement and the mean volume in cm3
and number of voxels. AAA comprising only the vessel wall
(yellow) 11.8 cm3 and 151 voxels, blood in the vena cava (red) 1.2
and 14, liver (purple upper right) 15.2 and 236 and suprarenal
aorta (green, upper right) 4.4 and 55 respectively.
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Due to the fact that no previous studies on aortic pathol-
ogies exist with [11C]-D-deprenyl, an autoradiography study
on AAA tissue was performed to validate our in vivo ﬁnd-
ings. Sections of AAA tissue, 20-mm thick, were incubated
with 10 nM [11C]-D-deprenyl, in phosphate-buffered saline
(PBS), pH 7.4, supplemented with 1% bovine serum albumin
(BSA), in the absence or presence of 1 mM of unlabelled D-
deprenyl (for assessment of non-speciﬁc binding). After
40 min of incubation at room temperature, the slides were
washed 3  3 min in cold PBS, dried and exposed to
phosphor imaging plates for 60 min. The plates were then
scanned in a Phosphor Imager Model 400S using 100-mm
pixel width (Molecular Dynamics, Sunnyvale, CA, USA) and
the digital images were analysed using software Image-
Quant 5.1 (Molecular Dynamics).Table 2. Histological criteria for grading the inﬂammatory inﬁltrate
in AAA.
Total inﬂammation
Grade 0 No inﬂammation
Grade 1 Sparse scattered chronic inﬂammatory cells or an
occasional small focus of inﬂammatory cells
Grade 2 Multiple small foci of inﬂammatory cells
Grade 3 Multiple large foci of inﬂammatory cells or
a diffuse, heavy inﬂammatory cellular inﬁltrate
Macrophage/neutrophil inﬁltration
Grade 0 No macrophages or neutrophils
Grade 1 0e20 cells
Grade 2 21e50 cells
Grade 3 >50 cells
Total inﬂammation calculated on the entire section. Macrophage/
neutrophil inﬁltration calculated in 10 powers magniﬁcation on
a 1 mm2 square.Histological protocol
The biopsies were 10  40 mm, consisting of the full
thickness of the aortic vessel wall, and were immediately
ﬁxed in formaldehyde in the operating room, processed for
histology and sections were cut and stained.
The total inﬂammatory load was evaluated on routine
haematoxylin and eosin-stained slices. For further catego-
risation and quantiﬁcation of the inﬂammation, immuno-
histochemical stainings were used. Antibodies against
lymphocytes (CD3), B lymphocytes (CD20) and macro-
phages/neutrophils (MAC387) were analysed in the full
thickness of the sample and in the different wall layers. The
MAC387 antibody detects the leukocyte L1 (cystic ﬁbrosis
antigen) found on neutrophils, monocytes and macro-
phages.14 The total inﬂammatory cell inﬁltrate was analysedon the entire section and graded according to Matthias
Bechte’s score15 (Table 2) and the MAC 387-positive cells
were calculated using 10-power magniﬁcation within
a square of 1 mm and graded according to a modiﬁed
macrophage/neutrophil inﬁltration score16 (Table 2).
Statistical analysis
The AAA wall was compared with the suprarenal aorta and
blood by means of (1) visual inspection, (2) SUV uptake and
(3) dynamic/retention index. The Wilcoxon’s Signed Rank
and ManneWhitney U tests were used to compare SUV
values and retention index. A value of P < 0.05 was
considered signiﬁcant. In addition the Pearson’s correlation
coefﬁcient was used to compare the correlation between
AAA expansion and SUV-value/retention index. A value
<0.5 or >0.5 was considered a strong correlation.
Statistical evaluation was carried out with Predictive
Analytics SoftWare (PASW) 18 software (IBM Corp.,
Armonk, NY, USA).
RESULTS
No visual uptake of the two tracers [11C]-PK11195 or [11C]-D-
deprenyl was seen in the aorta. No accumulation of radio-
activity in the aneurysm wall was seen in the dynamics
series (Figs. 2 and 3) or in SUV values; the median SUV in
the AAA wall was 0.9 (range 0.8e1.0) for [11C]-PK11195 and
0.7 (range 0.4e1.2) for [11C]-D-deprenyl. No differences in
SUV uptake (0.55, range0.03e0.62, P¼ 0.08) or retention
index (0.004, range 0.002e0.004, P ¼ 0.11) were seen
between non-aneurysmal suprarenal aorta and AAAs for
[11C]-PK11195. Compared to the aneurysm wall the non-
aneurysmal suprarenal aorta had a slightly higher [11C]-D-
deprenyl SUV uptake and retention index. The differences
were 0.48 (range 0.16e0.65, P ¼ 0.005) and 0.004 (0.001e
0.01, P ¼ 0.005), respectively.
No differences in SUV uptake between small and
large AAAs were seen for [11C]-PK11195, 0.0 versus 0.6
(P ¼ 0.4), or for [11C]-D-deprenyl 0.4 versus 0.5
(P ¼ 0.4). The mean expansion rate among the small AAAs
Figure 2. SUVmean 4D PET with [
11C]-PK11195. Blue continuous line represent the SUVmean of the AAA vessel wall, red interrupted line e
blood, green continuous e liver and black interrupted represents the SUVmean of suprarenal aortic vessel wall.
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to 0.2 mm) with a follow-up time of 36e120 months. No
correlation between expansion rate and SUV uptake was
seen (correlation coefﬁcient 0.3, P ¼ 0.62).
No uptake of [11C]-D-deprenyl in AAA tissue was seen
with autoradiography. The speciﬁc binding was <1%.
Histological examination of the nine aneurysms operated
on revealed a high degree of inﬂammatory cells with B- and
T-cells lymphocytes as well as macrophages (Table 3).
DISCUSSION
With PET/CT technology pathophysiological processes on
a molecular level can be detected in vivo, which makes it an
important potential research tool to elucidate the mostlyFigure 3. SUVmean 4D PET with [
11C]-D-deprenyl. Blue continuous line re
blood, green continuous e liver and black interrupted represents theunknown mechanism behind aneurysmal disease. We have
previously shown that the chronic inﬂammation observed in
the wall of large asymptomatic AAAs is not sufﬁciently
metabolically active to be detected by FDG-PET.4 In the
present report two additional tracers, previously shown to
be associated with other inﬂammatory conditions, [11C]-
PK11195 and [11C]-D-deprenyl were evaluated in patients
with small and large AAAs. This has never been investigated
previously.
[11C]-PK11195 binds to the translocator protein (18 kDa)
(TSPO), which is known to be expressed on macrophages.
Pugliese et al. showed an increased [11C]-PK11195 uptake in
patients with active large-vessel vasculitis,10 which is asso-
ciated with cell-mediated immunity characterised bypresent the SUVmean of the AAA vessel wall, red interrupted line e
SUVmean of suprarenal aortic vessel wall.
Table 3. Histological and immunohistochemical analysis of the aneurysmal wall of the nine patients operated on for AAA.
Patient Tracera Total inﬂammation scoreb T-/B-lymphocytes (%)c Macrophage/neutrophil inﬁltrate scored SUVmean AAA
1 PKB Grade 2 75/25 Grade 3 0.81
2 PKB Grade 3 50/50 Grade 3 0.92
3 PKB Grade 2 50/50 Grade 2 0.80
4 PKB Grade 2 50/50 Grade 2 1.02
5 DDE Grade 2 100/0 Grade 2 0.44
6 DDE Grade 2 90/10 Grade 3 0.73
7 DDE Grade 2 75/25 Grade 3 0.83
8 DDE Grade 3 50/50 Grade 3 0.75
9 DDE Grade 3 50/50 Grade 3 1.23
a PKB ¼ [11C]-PK11195, DDE ¼ [11C]-D-deprenyl.
b Evaluated on routine haematoxylineeosin stained slices.
c Antibodies against T-lymphocytes (CD3) and B-lymphocytes (CD20).
d Antibodies against macrophages/neutrophils (MAC387).
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cells, natural killer (NK) cells and neutrophils.17,18 Despite
some histological similarities between vasculitis and AAA,
there are important clinical differences, where active
vasculitis shows signs of systemic effects, such as illness
with fewer and elevated inﬂammatory laboratory markers.
Nevertheless, the observed uptake in active vaculitis
demonstrates that the tracer reaches the wall and binds to
inﬂammatory cells relevant also for AAA.
A high uptake of [11C]-D-deprenyl was seen in arthritis in
patients with rheumatoid arthritis, which decreased after
intra-articular glucocorticoid treatment.11 The inﬂammatory
process in arthritis is complex, with a large variety of cell
populations, for example, lymphocytes, innate immune
cells, synovial ﬁbroblasts and osteoclasts, along with
neutrophils, mast cells and a cascade of pro-inﬂammatory
cytokines and chemokines.19
Patients with chronic neck pain after whiplash injuries
were investigated with [11C]-D-deprenyl by Linnman et al.,
who showed SUV uptake as high as 5 in the affected
muscles suggesting an intense chronic inﬂammation.13 The
exact mechanism in whiplash-associated disorders (WADs)
is, however, not fully understood.20 Experimental studies
suggest that the repair process involves a complex cascade
of cellular events with immune cells and ﬁbroblasts where
both lymphocytes and macrophages play a role.21,22
In the literature, as well as in the present report, histo-
logical examinations of the large asymptomatic AAAs have
consistently shown a large number of inﬂammatory cells,
including macrophages. Even so, we found no [11C]-
PK11195 uptake, neither in small nor in large AAAs, which
indicates that the macrophages in the AAA wall are insuf-
ﬁciently activated in asymptomatic AAAs. Macrophages may
still be active but not activated via the intracellular pathway,
which consists of TSPO, and therefore are unable to bind
the radio ligand. Although the actual mechanism of [11C]-D-
deprenyl is not known, it can be hypothesised from the
present report that the binding sites are not located within
the vessel wall of asymptomatic AAAs, as no increased
uptake was seen in either small or large AAAs. This was also
veriﬁed by means of autoradiography and together with the
molecular characteristics of D-deprenyl this indicates that
the mechanism is lack of binding sites in the tissue, and notinability of the tracer to reach the tissue in vivo, which
makes the [11C]-D-deprenyl tracer unsuitable for in vivo
studies of asymptomatic AAAs.
The previously observed lack of FDG uptake in the wall of
AAA indicates that the chronic inﬂammation seen in large
AAA specimens is metabolically inactive, which is further
supported by the ﬁndings of the present study. The role of
inﬂammation in the early pathophysiological process of AAA
is yet to be deﬁned. In fact, there is as of today no evidence of
a signiﬁcant role for inﬂammation in small AAAs. Whether
the inﬂammatory inﬁltrate seen in large AAAs is a continua-
tion of an aetiological or pathophysiological process or
merely a reactive process to connective tissue degradation
initiated by other mechanisms remains to be established.
For in vivo molecular imaging studies of asymptomatic
AAAs, other PET tracers need to be developed.
CONCLUSION
The radio ligands [11C]-PK11195 and [11C]-D-deprenyl,
previously associated with high uptake in molecular imaging
of inﬂammatory conditions, are not suitable to detect and
characterise the chronic inﬂammation seen in the wall of
asymptomatic AAAs. For in vivo molecular imaging studies
of asymptomatic AAAs other PET tracers need to be
developed.
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